Tag: denosumab

A drug-target Mendelian randomization study found that genetically elevated osteoprotegerin levels are associated with a reduced risk of type 2 ...

A new review argues that type 2 diabetes combines higher fracture risk with lower circulating bone-turnover markers and non-low bone ...

A new review maps how mutations in more than twenty genes weaken bone in osteogenesis imperfecta and surveys therapies from ...

A comprehensive analytical characterization shows the newly approved denosumab biosimilar SB16 is highly similar to Prolia and Xgeva across structure, ...

A three-year prospective cohort study of 186 postmenopausal women with osteoporosis found that denosumab was associated with greater gains in ...

A multigenerational case report identified a previously unreported likely pathogenic COL1A1 frameshift variant in a 13-year-old boy with blue sclerae ...

A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...

A nationwide Finnish registry study of 652 breast cancer patients with bone metastases found jawbone necrosis in 12.6 percent of ...

A nationwide Finnish cohort study found that people with Parkinson's disease receive anti-osteoporosis medications at rates similar to or higher ...

Recent advancements in osteoporosis treatment reveal an intriguing correlation between renal function and the efficacy of romosozumab following denosumab administration ...